Arkadios Wealth Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-75
| Closed | -$30K | – | 802 |
|
|
2021
Q3 | $30K | Sell |
75
-122
| -62% | -$48.8K | ﹤0.01% | 1066 |
|
|
2021
Q2 | $72K | Buy |
197
+9
| +5% | +$3.29K | 0.01% | 812 |
|
|
2021
Q1 | $54K | Sell |
188
-4
| -2% | -$1.15K | 0.01% | 670 |
|
|
2020
Q4 | $47K | Buy |
192
+56
| +41% | +$13.7K | 0.01% | 568 |
|
|
2020
Q3 | $32.7K | Sell |
136
-5
| -4% | -$1.2K | 0.02% | 490 |
|
|
2020
Q2 | $26.4K | Sell |
141
-28
| -17% | -$5.25K | 0.01% | 487 |
|
|
2020
Q1 | $21.3K | Sell |
169
-29
| -15% | -$3.66K | 0.01% | 476 |
|
|
2019
Q4 | $34.1K | Buy |
+198
| New | +$34.1K | 0.02% | 370 |
|